newsfilter
← Latest News
GlobeNewswire·

Aclaris Therapeutics Announces Formation of New Scientific Advisory Board

WAYNE, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today